vs

Side-by-side financial comparison of Oncology Institute, Inc. (TOI) and WW INTERNATIONAL, INC. (WW). Click either name above to swap in a different company.

WW INTERNATIONAL, INC. is the larger business by last-quarter revenue ($184.3M vs $142.0M, roughly 1.3× Oncology Institute, Inc.). Oncology Institute, Inc. runs the higher net margin — -5.3% vs -30.5%, a 25.2% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -4.5%). WW INTERNATIONAL, INC. produced more free cash flow last quarter ($8.4M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -7.4%).

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

WW International, Inc., formerly Weight Watchers International, Inc., is a global company headquartered in the U.S. that offers weight loss and maintenance, fitness, and mindset services such as the Weight Watchers comprehensive diet program. Founded in 1963 by Queens, New York City homemaker Jean Nidetch, WW's program has three options as of 2019: online via its mobile app and website, coaching online or by phone, or in-person meetings.

TOI vs WW — Head-to-Head

Bigger by revenue
WW
WW
1.3× larger
WW
$184.3M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+46.1% gap
TOI
41.6%
-4.5%
WW
Higher net margin
TOI
TOI
25.2% more per $
TOI
-5.3%
-30.5%
WW
More free cash flow
WW
WW
$6.2M more FCF
WW
$8.4M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-7.4%
WW

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
TOI
TOI
WW
WW
Revenue
$142.0M
$184.3M
Net Profit
$-7.5M
$-56.3M
Gross Margin
72.2%
Operating Margin
-4.9%
5.8%
Net Margin
-5.3%
-30.5%
Revenue YoY
41.6%
-4.5%
Net Profit YoY
43.0%
-21.8%
EPS (diluted)
$-0.04
$-5.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TOI
TOI
WW
WW
Q4 25
$142.0M
Q3 25
$136.6M
$184.3M
Q2 25
$119.8M
Q1 25
$104.4M
$186.6M
Q4 24
$100.3M
$184.4M
Q3 24
$99.9M
$192.9M
Q2 24
$98.6M
$202.1M
Q1 24
$94.7M
$206.5M
Net Profit
TOI
TOI
WW
WW
Q4 25
$-7.5M
Q3 25
$-16.5M
$-56.3M
Q2 25
$-17.0M
Q1 25
$-19.6M
$-72.6M
Q4 24
$-13.2M
$25.1M
Q3 24
$-16.1M
$-46.2M
Q2 24
$-15.5M
$23.3M
Q1 24
$-19.9M
$-347.9M
Gross Margin
TOI
TOI
WW
WW
Q4 25
Q3 25
72.2%
Q2 25
Q1 25
71.2%
Q4 24
69.7%
Q3 24
67.1%
Q2 24
67.9%
Q1 24
66.7%
Operating Margin
TOI
TOI
WW
WW
Q4 25
-4.9%
Q3 25
-5.9%
5.8%
Q2 25
-9.4%
Q1 25
-9.5%
-10.8%
Q4 24
-11.9%
19.6%
Q3 24
-13.9%
-20.2%
Q2 24
-16.6%
17.8%
Q1 24
-19.0%
-130.4%
Net Margin
TOI
TOI
WW
WW
Q4 25
-5.3%
Q3 25
-12.1%
-30.5%
Q2 25
-14.2%
Q1 25
-18.8%
-38.9%
Q4 24
-13.1%
13.6%
Q3 24
-16.1%
-23.9%
Q2 24
-15.7%
11.5%
Q1 24
-21.0%
-168.4%
EPS (diluted)
TOI
TOI
WW
WW
Q4 25
$-0.04
Q3 25
$-0.14
$-5.63
Q2 25
$-0.15
Q1 25
$-0.21
$-0.91
Q4 24
$-0.14
$0.34
Q3 24
$-0.18
$-0.58
Q2 24
$-0.17
$0.29
Q1 24
$-0.22
$-4.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TOI
TOI
WW
WW
Cash + ST InvestmentsLiquidity on hand
$170.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$-15.7M
$323.0M
Total Assets
$164.7M
$968.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TOI
TOI
WW
WW
Q4 25
Q3 25
$170.1M
Q2 25
Q1 25
$236.3M
Q4 24
$53.0M
Q3 24
$57.2M
Q2 24
$9.9M
$42.7M
Q1 24
$29.8M
$66.6M
Total Debt
TOI
TOI
WW
WW
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.4B
Q3 24
$1.4B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
TOI
TOI
WW
WW
Q4 25
$-15.7M
Q3 25
$-12.3M
$323.0M
Q2 25
$-9.0M
Q1 25
$5.1M
$-1.2B
Q4 24
$3.6M
$-1.1B
Q3 24
$15.5M
$-1.1B
Q2 24
$29.2M
$-1.1B
Q1 24
$41.3M
$-1.1B
Total Assets
TOI
TOI
WW
WW
Q4 25
$164.7M
Q3 25
$163.6M
$968.8M
Q2 25
$159.8M
Q1 25
$164.0M
$696.9M
Q4 24
$172.7M
$550.3M
Q3 24
$179.2M
$562.4M
Q2 24
$179.6M
$614.3M
Q1 24
$204.5M
$654.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TOI
TOI
WW
WW
Operating Cash FlowLast quarter
$3.2M
$8.4M
Free Cash FlowOCF − Capex
$2.2M
$8.4M
FCF MarginFCF / Revenue
1.5%
4.6%
Capex IntensityCapex / Revenue
0.7%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M
$44.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TOI
TOI
WW
WW
Q4 25
$3.2M
Q3 25
$-12.6M
$8.4M
Q2 25
$-10.2M
Q1 25
$-5.0M
$15.0M
Q4 24
$4.2M
$4.6M
Q3 24
$819.0K
$16.5M
Q2 24
$-15.7M
$-1.9M
Q1 24
$-15.9M
$-36.0M
Free Cash Flow
TOI
TOI
WW
WW
Q4 25
$2.2M
Q3 25
$-13.2M
$8.4M
Q2 25
$-11.4M
Q1 25
$-5.3M
$15.0M
Q4 24
$2.4M
$4.5M
Q3 24
$417.0K
$16.4M
Q2 24
$-17.5M
$-2.2M
Q1 24
$-16.5M
$-36.5M
FCF Margin
TOI
TOI
WW
WW
Q4 25
1.5%
Q3 25
-9.7%
4.6%
Q2 25
-9.5%
Q1 25
-5.1%
8.0%
Q4 24
2.4%
2.4%
Q3 24
0.4%
8.5%
Q2 24
-17.7%
-1.1%
Q1 24
-17.4%
-17.7%
Capex Intensity
TOI
TOI
WW
WW
Q4 25
0.7%
Q3 25
0.4%
0.0%
Q2 25
1.0%
Q1 25
0.3%
0.0%
Q4 24
1.8%
0.1%
Q3 24
0.4%
0.1%
Q2 24
1.9%
0.1%
Q1 24
0.6%
0.2%
Cash Conversion
TOI
TOI
WW
WW
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.18×
Q3 24
Q2 24
-0.08×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

WW
WW

Segment breakdown not available.

Related Comparisons